Krystal Biotech, Inc. (KRYS)

Import this data to Google Sheets with:

=jivedata("KRYS","financials")

Full statements spill as a table. For one cell: =jivedata("KRYS","Revenue") or =jivedata("KRYS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Krystal Biotech, Inc.

KRYS • CIK 0001711279

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$358,328	$344,865	$496,304	$427,740
Debt Securities, Available-for-sale, Current	$173,850	$252,652	$331,487	$417,891
Property, Plant and Equipment, Net	$161,202	$155,168	$150,776	$153,775
Accounts Receivable, after Allowance for Credit Loss, Current	$42,040	$104,746	$127,425	$138,662
Long-term Investments	$61,954	$152,114	$128,066	$257,291
Inventory, Net	$6,985	$26,508	$40,475	$45,556
Operating Lease, Right-of-Use Asset	$7,027	$6,280	$7,239	$6,826
Prepaid Taxes	—	—	$14,006	$15,308
Deferred Income Tax Assets, Net	—	—	$22,824	$22,824
Prepaid Expense and Other Assets, Current	$6,706	$13,274	$14,905	$14,491
Other Assets, Noncurrent	$263	$231	$287	$284
Assets, Current	$587,909	$742,045	$1,024,602	$1,059,648
Assets	$818,355	$1,055,838	$1,333,794	$1,500,648
Operating Lease, Liability, Noncurrent	$6,620	$6,044	$7,568	$7,045
Other Liabilities, Noncurrent	—	$1,419	$3,724	$7,080
Liabilities	$39,714	$109,458	$114,234	$141,522
Accounts Payable, Current	$4,132	$4,985	$3,238	$6,544
Operating Lease, Liability, Current	$1,474	$1,217	$1,771	$1,808
Accounts Payable and Other Accrued Liabilities, Current	$27,488	$58,989	$39,752	$35,565
Liabilities, Current	$33,094	$101,995	$102,942	$127,397
Common Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital	$1,047,830	$1,127,238	$1,194,261	$1,228,598
Accumulated Other Comprehensive Income (Loss), Net of Tax	$638	$-190	$1,136	$-4,335
Retained Earnings (Accumulated Deficit)	$-269,827	$-180,668	$24,163	$134,863
Stockholders' Equity Attributable to Parent	$778,641	$946,380	$1,219,560	$1,359,126
Common Stock, Shares Authorized	80,000,000	80,000,000	80,000,000	80,000,000
Common Stock, Shares, Issued	28,236,673	28,794,000	29,192,000	29,596,000
Inventory, Raw Materials, Net of Reserves	$3,154	$13,639	$15,938	$15,259
Inventory, Work in Process, Net of Reserves	$3,204	$10,743	$15,224	$20,937
Inventory, Finished Goods, Net of Reserves	$627	$2,126	$9,313	$9,360
Property, Plant and Equipment, Gross	$174,029	$177,087	$182,057	$190,147
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$12,827	$21,919	$31,281	$36,372
Depreciation	$5,007	$5,967	$5,724	$2,878
Accrued Income Taxes	$2,283	$4,288	$10,919	$14,810
Accrued Professional Fees, Current	$1,810	$2,659	$5,936	$4,842
Other Liabilities, Current	$2,210	$2,403	$3,579	$3,428
Estimated Litigation Liability, Current	—	$31,250	$0	$0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-156	$-458	$286	$-4,106
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$196,428	$-13,463	$151,439	$73,911
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$358,328	$344,865	$496,304	$688,847
Net Income (Loss) Attributable to Parent	$10,932	$89,159	$204,831	$241,464
Net Cash Provided by (Used in) Operating Activities	$-88,804	$123,420	$200,865	$272,338
Proceeds from Sale of Property, Plant, and Equipment	—	—	$435	$0
Proceeds from Sale of Intangible Assets	$100,000	$0	$0	$0
Payments to Acquire Property, Plant, and Equipment	$11,799	$4,238	$11,951	$14,556
Payments to Acquire Debt Securities, Available-for-sale	$508,776	$457,740	$422,540	$422,540
Proceeds from Sale, Maturity and Collection of Short-term Investments	$503,213	$298,539	$375,639	$385,157
Net Cash Provided by (Used in) Investing Activities	$82,638	$-163,439	$-58,417	$-218,290
Proceeds from Issuance of Common Stock	$203,499	$0	$0	$0
Proceeds from Stock Options Exercised	—	$32,400	$22,661	$41,065
Payment, Tax Withholding, Share-based Payment Arrangement	$749	—	—	$749
Net Cash Provided by (Used in) Financing Activities	$202,750	$27,014	$8,705	$23,969
Capital Expenditures Incurred but Not yet Paid	$8,602	$8,497	$3,067	$2,181
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	$0	$1,786	$-8
Income Taxes Paid	—	—	$15,673	$15,638
Increase (Decrease) in Deferred Income Taxes	—	—	$22,845	$22,845
Depreciation	$5,007	$5,967	$5,724	$5,843
Operating Lease, Right-of-Use Asset, Amortization Expense	—	$747	$827	$823
Share-based Payment Arrangement, Noncash Expense	$39,933	$49,127	$54,514	$54,682
Realized Investment Gains (Losses)	$5,092	$6,069	$5,953	$2,974
Other Operating Activities, Cash Flow Statement	$-451	$652	$684	$304
Increase (Decrease) in Accounts Receivable	$42,040	$62,706	$22,124	$27,346
Increase (Decrease) in Inventories	$4,475	$11,907	$6,286	$6,972
Increase (Decrease) in Prepaid Taxes	—	—	$12,389	$12,743
Increase (Decrease) in Prepaid Expense and Other Assets	$908	$8,909	$2,270	$1,205
Increase (Decrease) in Other Noncurrent Liabilities	—	$1,419	$2,280	$4,374
Increase (Decrease) in Accounts Payable	$-101	$1,011	$826	$-124
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$4,558	$5,391	$14,104	$10,829

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("KRYS","financials")

Full statements spill as a table. For one cell: =jivedata("KRYS","Revenue") or =jivedata("KRYS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.